We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prevalence and Clinical Spectrum of the 22q11 Deletion

This study has been terminated.
(sufficient data collected)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00267397
First Posted: December 21, 2005
Last Update Posted: May 4, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Children's Healthcare of Atlanta
December 19, 2005
December 21, 2005
May 4, 2007
January 1967
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00267397 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Prevalence and Clinical Spectrum of the 22q11 Deletion
Prevalence and Clincial Spectrum of the 22q11 Deletion: A Population Based Study of Children and Congenital Heart Defects
The purpose of this project is to conduct population based surveillance for prenatally diagnosed congenital defects amount residents of the five counties to: improve the comprehensiveness of the Metropolitan Atlanta Congenital Defects Program (MACDP) to (1) better fulfill its objectives (2) allow assessment of the impact of prenatal diagnosis and elective termination on the birth prevalence of congenital defects in Atlanta (3) develop a registry of prenatally diagnosed defects to be used in epidemiologic and genetic studies, in evaluation prevention programs and in monitoring prenatal diagnostic technology.

Since 1967, The Centers for Disease Control and Prevention (CDC) has conducted surveillance of birth defects in metropolitan Atlanta through review of hospital delivery and newborn medical records and records from various other medical sources in the five central counties of the metropolitan area (Clayton, Cobb, DeKalk, Fulton and Gwinnett, and has been expanded to include prenatal records. The project was begun n the aftermath of thalidomide and rubella epidemics as a kind of early-warning system for new or resurgent teratogens. The voluntary participation of Atlanta hospitals was sought and obtained at the inception of the system (the original system was a joint effort of the CDC, the Georgia Institute of Mental Health and Emory University).

A case must be diagnosed by the child's sixth birthday or within six years of the date of elective termination.

Children's Healthcare is one retrospective source of medical records reviewed for discharge summaries and disease indices.

Observational
Observational Model: Defined Population
Observational Model: Natural History
Time Perspective: Longitudinal
Time Perspective: Retrospective
Not Provided
Not Provided
Not Provided
Not Provided
Congenital Disorders
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Terminated
Not Provided
December 2006
Not Provided

Inclusion Criteria:

  • birth defect diagnosed by the child's sixth birthday
  • birth defect diagnosed within 6 years of the elective date of termination

Exclusion Criteria:

  • those who do not meet inclusion criteria
Sexes Eligible for Study: All
up to 6 Years   (Child)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00267397
01-107
No
Not Provided
Not Provided
Not Provided
Children's Healthcare of Atlanta
Not Provided
Principal Investigator: Robert M. Campbell, MD Children's Healthcare of Atlanta
Children's Healthcare of Atlanta
May 2007